CASC4 antibody
Principal name
CASC4 antibody
Alternative names for CASC4 antibody
Cancer susceptibility candidate gene 4 protein
Ncbi ID
NP_612432, NM_138423, NP_612432.2, NP_001192298.1, NM_177054, NM_199038
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of CASC4 antibody
- Kit Component:
- - KN302556G1, Casc4 gRNA vector 1 in pCas-Guide vector
- KN302556G2, Casc4 gRNA vector 2 in pCas-Guide vector
- KN302556D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
CASC4 Antibody (C-term) (Cat. #AP50730PU-N) western blot analysis in mouse Neuro-2a cell line lysates (35µg/lane).This demonstrates the CASC4 antibody detected the CASC4 protein (arrow).
Host: Rabbit; Target Name: CASC4; Sample Tissue: Fetal Liver lysates; Antibody Dilution: 1.0 ug/ml.
Host: Rabbit; Target Name: CASC4; Sample Tissue: MCF7 Whole Cell lysates; Antibody Dilution: 1.0 ug/ml.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP50730PU-N | CASC4 (C-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu, Ms | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY408679 | CASC4 overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR216741L2V | Lenti ORF particles, Casc4 (GFP-tagged) - Mouse cancer susceptibility candidate 4 (Casc4), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR218218L2V | Lenti ORF particles, Casc4 (GFP-tagged) - Mouse cancer susceptibility candidate 4 (Casc4), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR216741L1V | Lenti ORF particles, Casc4 (Myc-DDK-tagged) - Mouse cancer susceptibility candidate 4 (Casc4), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
| MR218218L1V | Lenti ORF particles, Casc4 (Myc-DDK-tagged) - Mouse cancer susceptibility candidate 4 (Casc4), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
